Jane Street
IBRX icon

Jane Street’s ImmunityBio IBRX Stock Holding History

Jane Street’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.4M Buy
703,900
+556,900
+379% +$3.81M ﹤0.01% 3394
2025
Q4 		$291K Buy
147,000
+113,900
+344% +$258K ﹤0.01% 8903
2025
Q3 		$81.4K Sell
33,100
-64,300
-66% -$166K ﹤0.01% 10217
2025
Q2 		$257K Buy
97,400
+39,200
+67% +$105K ﹤0.01% 8121
2025
Q1 		$175K Sell
58,200
-61,700
-51% -$187K ﹤0.01% 8540
2024
Q4 		$307K Buy
119,900
+57,000
+91% +$237K ﹤0.01% 7702
2024
Q3 		$234K Sell
62,900
-13,000
-17% -$60.2K ﹤0.01% 8420
2024
Q2 		$480K Sell
75,900
-28,900
-28% -$191K ﹤0.01% 7086
2024
Q1 		$563K Buy
104,800
+88,900
+559% +$403K ﹤0.01% 6453
2023
Q4 		$79.8K Sell
15,900
-600
-4% -$1.88K ﹤0.01% 8665
2023
Q3 		$27.9K Sell
16,500
-4,600
-22% -$9.24K ﹤0.01% 8261
2023
Q2 		$58.7K Buy
21,100
+1,100
+6% +$3.11K ﹤0.01% 8178
2023
Q1 		$36.4K Sell
20,000
-75,700
-79% -$235K ﹤0.01% 8528
2022
Q4 		$485K Sell
95,700
-30,400
-24% -$167K ﹤0.01% 6185
2022
Q3 		$627K Buy
126,100
+87,300
+225% +$398K ﹤0.01% 6258
2022
Q2 		$144K Sell
38,800
-54,700
-59% -$220K ﹤0.01% 8434
2022
Q1 		$525K Buy
93,500
+34,900
+60% +$214K ﹤0.01% 7382
2021
Q4 		$356K Buy
58,600
+21,300
+57% +$160K ﹤0.01% 7864
2021
Q3 		$363K Sell
37,300
-32,300
-46% -$355K ﹤0.01% 7829
2021
Q2 		$994K Sell
69,600
-113,600
-62% -$1.88M ﹤0.01% 5859
2021
Q1 		$4.35M Buy
183,200
+23,000
+14% +$596K ﹤0.01% 2608
2020
Q4 		$2.13M Buy
160,200
+142,000
+780% +$1.37M ﹤0.01% 3376
2020
Q3 		$126K Sell
18,200
-30,400
-63% -$303K ﹤0.01% 6675
2020
Q2 		$597K Buy
+48,600
New +$274K ﹤0.01% 4804

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Jane Street's IBRX Position: Q1 2026 in Review

Jane Street reduced its ImmunityBio (IBRX) stake by 95% in Q1 2026, selling an estimated $92.6M and leaving 704,232 shares worth $5.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Jane Street first reported a position in IBRX in Q2 2019 and has held it in 24 quarters since. The position peaked at $31.6M in Q3 2025. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Jane Street held 704,232 shares of ImmunityBio worth $5.4M as of Q1 2026.
  • Jane Street sold 13,519,992 ImmunityBio shares in Q1 2026, an estimated $92.6M.
  • ImmunityBio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3393 holding.
  • Jane Street first reported a position in ImmunityBio in Q2 2019 and has held it in 24 quarters since.
  • Jane Street's ImmunityBio position peaked at $31.6M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.